A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of pressure from U.S. Sen. Maggie Hassan, D-N.H. Without warning in ...
Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...
Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Following use of race-neutral lung function equations, African American and Latino pediatric ...
One out of every 12 school-age children has asthma, which is the most common reason for missed school days. Any time a child develops asthma symptoms, it’s worth looking at what they ate, touched, or ...
Life as a teenager and older adolescent is defined by turbulence. Normal body changes and hormonal shifts cause emotional and social challenges. As high school ends and adulthood begins, this ...
A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of pressure from U.S. Sen. Maggie Hassan, D-N.H. Without warning in ...
The change will make asthma infusion treatments a pharmacy benefit, meaning policyholders will have to self-inject these four asthma infusion medications. Mykal McEldowney/IndyStar USA TODAY NETWORK A ...
Starting this April, the biggest health insurer in Texas plans to restrict treatment options for patients suffering from severe asthma. Blue Cross Blue Shield — which covers more than 10 million ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results